已收盘 02-06 16:00:00 美东时间
+1.290
+6.70%
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
2025-11-14 10:43
B of A Securities analyst Curtis Nagle maintains Ibotta (NYSE:IBTA) with a Underperform and lowers the price target from $24 to $22.
2025-11-13 20:50
Ibotta shares are trading lower. The company reported Q3 financial results.
2025-11-13 05:18
Ibotta (NYSE:IBTA) sees Q4 sales of $80.000 million-$85.000 million vs $84.148 million analyst estimate.
2025-11-13 05:13
Ibotta (NYSE:IBTA) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.00 by 18566.67 percent. This is a 40.43 percent decrease over earnings of $0.94 per share from the same
2025-11-13 05:13
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
今日重点评级关注:Roth Capital:维持Cingulate"买入"评级,目标价从10美元升至17美元;JMP证券:维持BioCryst Pharma"跑赢大市"评级,目标价从17美元升至27美元
2025-10-16 10:43
Ratings for Ibotta (NYSE:IBTA) were provided by 7 analysts in the past three mo...
2025-10-16 05:00
Goldman Sachs analyst Eric Sheridan downgrades Ibotta (NYSE:IBTA) from Neutral to Sell and lowers the price target from $30 to $26.
2025-10-15 18:58